Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 72351 - 72375 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	PPP1R3C	5507	downregulated	Silicon Dioxide results in decreased expression of PPP1R3C mRNA	10q23.32	A24196
Silicon dioxide	Approved	PPP2R1B	5519	upregulated	Silicon Dioxide results in increased expression of PPP2R1B mRNA	11q23.1	A24196
Silicon dioxide	Approved	PPP2R3A	5523	upregulated	Silicon Dioxide results in increased expression of PPP2R3A mRNA	3q22.2-q22.3	A24196
Silicon dioxide	Approved	PPP6R1	22870	upregulated	Silicon Dioxide analog results in increased expression of PPP6R1 mRNA	19q13.42	A24195
Silicon dioxide	Approved	PPRC1	23082	upregulated	Silicon Dioxide analog results in increased expression of PPRC1 mRNA	10q24.32	A24195
Silicon dioxide	Approved	PQLC2L	152078	upregulated	Silicon Dioxide analog results in increased expression of PQLC2L mRNA	3q25.32	A24195
Silicon dioxide	Approved	PQLC3	130814	downregulated	Silicon Dioxide analog results in decreased expression of PQLC3 mRNA	2p25.1	A24195
Silicon dioxide	Approved	PRAMEF10	343071	downregulated	Silicon Dioxide analog results in decreased expression of PRAMEF10 mRNA	1p36.21	A24194
Silicon dioxide	Approved	PRB1	5542	upregulated	Silicon Dioxide analog results in increased expression of PRB1 mRNA	12p13.2	A24194
Silicon dioxide	Approved	PRC1	9055	upregulated	Silicon Dioxide results in increased expression of PRC1 mRNA	15q26.1	A24196
Silicon dioxide	Approved	PRDM1	639	upregulated	Silicon Dioxide results in increased expression of PRDM1 mRNA	6q21	A24196
Silicon dioxide	Approved	PRDM13	59336	upregulated	Silicon Dioxide analog results in increased expression of PRDM13 mRNA	6q16.2	A24195
Silicon dioxide	Approved	PRDM2	7799	upregulated	Silicon Dioxide results in increased expression of PRDM2 mRNA	1p36.21	A24196
Silicon dioxide	Approved	PRICKLE2	166336	downregulated	Silicon Dioxide analog results in decreased expression of PRICKLE2 mRNA	3p14.1	A24195
Silicon dioxide	Approved	PRIM1	5557	upregulated	Silicon Dioxide analog results in increased expression of PRIM1 mRNA	12q13.3	A24195
Silicon dioxide	Approved	PRIM1	5557	downregulated	Silicon Dioxide results in decreased expression of PRIM1 mRNA	12q13.3	A24196
Silicon dioxide	Approved	PRKAG2	51422	upregulated	Silicon Dioxide analog results in increased expression of PRKAG2 mRNA	7q36.1	A24195
Silicon dioxide	Approved	PRKAR1B	5575	upregulated	Silicon Dioxide analog results in increased expression of PRKAR1B mRNA	7p22.3	A24195
Silicon dioxide	Approved	PRKCD	5580	downregulated	Silicon Dioxide analog results in decreased expression of PRKCD mRNA	3p21.1	A24195
Silicon dioxide	Approved	PRKCE	5581	upregulated	Silicon Dioxide analog results in increased expression of PRKCE mRNA	2p21	A24195
Silicon dioxide	Approved	PRKD1	5587	downregulated	Silicon Dioxide analog results in decreased expression of PRKD1 mRNA	14q12	A24195
Silicon dioxide	Approved	PRKG2	5593	downregulated	Silicon Dioxide results in decreased expression of PRKG2 mRNA	4q21.21	A24196
Silicon dioxide	Approved	PRMT2	3275	downregulated	Silicon Dioxide results in decreased expression of PRMT2 mRNA	21q22.3	A24196
Silicon dioxide	Approved	PRND	23627	upregulated	Silicon Dioxide analog results in increased expression of PRND mRNA	20p13	A24194
Silicon dioxide	Approved	PROC	5624	downregulated	Silicon Dioxide analog results in decreased expression of PROC mRNA	2q14.3	A24195

Displaying entries 72351 - 72375 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability